Merlin Properties SOCIMI SA (MRL)
Euronext Lisbon · Portugal · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 11.31 |
|---|---|
| 52-week range | 11.18 – 16.36 |
| Return, 1 month / 3 months | −10.1% / −23.8% |
| Return, 1 year / 3 years | −16.7% / +60.1% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 33.6% |
| Worst drawdown (1 year) | -29.3% |
| Average daily value traded | 5.22M EUR |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Merlin Properties SOCIMI SA is a Spanish real estate investment company based in Madrid that owns and manages commercial property. Its portfolio centres on office buildings, shopping centres and logistics warehouses, mainly in Spain and Portugal. It leases space to corporate tenants and retail brands, and it operates as a tax-transparent real estate vehicle under the Spanish SOCIMI regime. The company also holds a stake in a fibre and data centre business, which adds digital infrastructure to its property activities.
On this site Merlin Properties SOCIMI SA appears as a stock on the Euronext Lisbon (Portugal), code MRL, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Merlin Properties SOCIMI SA (MRL) trades on the Euronext Lisbon in Portugal. It last closed at EUR 11.31 on 22 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 33 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.7% and over the last three months it fell 23.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 11 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.5% | ||
| From 52-week high | -29.3% | ||
| Momentum | 9 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -23.8% | ||
| 6-month return | -24.8% | ||
| 12-month return, skipping the last month | -7.4% | ||
| Stability (higher is calmer) | 28 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.3% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 5.22M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.1% |
|---|---|
| 1 month | −10.1% |
| 3 months | −23.8% |
| 6 months | −24.8% |
| 1 year | −16.7% |
| 3 years | +60.1% |
| 5 years | +51.5% |
Signals
| 50-day / 200-day average | 12.82 / 14.05 |
|---|---|
| Golden / death cross (60 days) | Death, 22 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.35 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | EUR 0.0122 |
| 21 Nov 2025 | EUR 0.1620 |
| 8 May 2025 | EUR 0.2009 |
| 22 Nov 2024 | EUR 0.1458 |
| 17 May 2024 | EUR 0.2316 |
| 24 Nov 2023 | EUR 0.1620 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.